Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression [Corrigendum]
Kamijima K, Hashimoto S, Nagayoshi E, Koyama T. Neuropsychiatric Disease and Treatment. 2013;9:555–565. On page 559, right column, line 10 from the bottom: (0.9 to 1.2) should read (−0.9 to 1.2).Read the original article
Main Authors: | Kamijima K, Hashimoto S, Nagayoshi E, Koyama T |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-06-01
|
Series: | Neuropsychiatric Disease and Treatment |
Online Access: | http://www.dovepress.com/corrigendum-double-blind-comparative-study-of-milnacipran-and-par-a13261 |
Similar Items
-
Milnacipran versus other antidepressive agents for depression.
by: Nakagawa, A, et al.
Published: (2009) -
Editorial Foreword - Milnacipran: recent findings in depression
by: Stuart Montgomery, et al.
Published: (2010-08-01) -
Experience with ixel (milnaciprane hydrochloride) treatment of poststroke depression
by: А В Gekht, et al.
Published: (2003-10-01) -
Plasma levels of interleukin-6 and 3-methoxy-4-hydroxyphenylglycol and treatment with milnacipran in major depression
by: Reiji Yoshimura, et al.
Published: (2022-08-01) -
Effect of milnacipran on suicidality in patients with mild to moderate depressive disorder
by: Alla Avedisova, et al.
Published: (2009-07-01)